Cash flows from operating activities: | |
Net income (loss) | |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |
Depreciation and amortization | |
Amortization of stock-based compensation costs | |
Payment of lender fees related to debt issuance | |
Provision for doubtful accounts | |
Deferred income taxes | |
(Gain) loss on divestiture of discontinued operations | |
Other | |
Change in operating assets and liabilities: | |
Accounts receivable | |
Inventories and other assets | |
Accounts payable | |
Income taxes | |
Due to third party payors | |
Other accrued liabilities | |
Net cash provided by operating activities | 36.08M |
Cash flows from investing activities: | |
Routine capital expenditures | -21.87M |
Development capital expenditures | -8.39M |
Acquisitions, net of cash acquired | -49.33M |
Sale of assets | 3.74M |
Purchase of insurance subsidiary investments | -22.43M |
Sale of insurance subsidiary investments | 31.88M |
Net change in insurance subsidiary cash and cash equivalents | -14.68M |
Change in other investments | |
Other | -150K |
Net cash used in investing activities | -81.18M |
Cash flows from financing activities: | |
Proceeds from borrowings under revolving credit | 489.2M |
Repayment of borrowings under revolving credit | -388.1M |
Proceeds from issuance of senior unsecured notes | 0 |
Proceeds from issuance of term loan, net of discount | 0 |
Repayment of other long-term debt | |
Payment of deferred financing costs | -50K |
Issuance of common stock | 0 |
Other | 35K |
Net cash provided by (used in) financing activities | 84.47M |
Change in cash and cash equivalents | 39.37M |
Cash and cash equivalents at beginning of period | 100.06M |
Cash and cash equivalents at end of period | 139.43M |
Supplemental information: | |
Issuance of common stock in RehabCare acquisition | |
Financing costs/Interest payments | |
Income tax payments (refunds) | |
RehabCare Acquisition [Member] | |
Supplemental information: | |
Financing costs/Interest payments |